Nexstim Plc (NXTMH)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Nexstim Plc (NXTMH) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011122
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:54
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フィンランド
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Nexstim Plc (Nexstim) is a medical technology company, which focuses on navigated brain stimulation (NBS) to improve rehabilitation in stroke patients non-invasively . Its NBS system, which is FDA cleared and CE-marked, applies navigated transcranial magnetic stimulation (nTMS) device for pre-surgical mapping of the motor and speech cortices. It is also used for research, therapy and neurosurgical planning purposes. Nexstim’s navigated brain therapy (NBT) system is based on the NBS technology platform, focusing on the stimulation of targeted areas in the brain to improve and accelerate stroke rehabilitation. The company offers its products in the US, Finland and other European countries through subsidiaries. Nexstim is headquartered in Helsinki, Finland.

Nexstim Plc (NXTMH) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Nexstim Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Nexstim Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Nexstim Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Nexstim Plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Nexstim Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Nexstim Plc, Medical Equipment, Deal Details 11
Venture Financing 11
Nexstim Secures Additional US$2.8 Million In Venture Financing Round 11
Partnerships 13
Nexstim Enters into Licensing Agreement with Chinese Partner 13
Nexstim Enters into Co-Operation Agreement with Walton Centre 14
Equity Offering 15
Nexstim to Raise USD2 Million in Private Placement of Shares 15
Nexstim to Raise USD5.5 Million in Private Placement of Shares 16
Nexstim to Raise USD2.2 Million in Private Placement of Shares 18
Nexstim Raises USD5.8 Million in Private Placement of Shares 20
Nexstim Raises USD19 Million in IPO 21
Debt Offering 22
Nexstim to Raise USD5.5 Million in Private Placement of Convertible Bond 22
Nexstim Plc – Key Competitors 24
Nexstim Plc – Key Employees 25
Nexstim Plc – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 27
Financial Announcements 27
Aug 17, 2017: Nexstim Half-yearly Report 1 January – 30 June 2016 (Unaudited) 27
Aug 16, 2017: Nexstim Half-Yearly Report 1 January – 30 June 2017 (Unaudited) 29
Jun 02, 2017: Nexstim Agrees on Extension of Tekes R&D Loan Repayments 31
Feb 28, 2017: Nexstim: Financial Statement Release 2016 32
Feb 29, 2016: Nexstim financial statement release 2015 34
Corporate Communications 36
Oct 12, 2017: Change in Nexstim Management Team 36
Sep 26, 2017: Change in Nexstim’s Management Team 37
Aug 03, 2017: Changes in Nexstim’s Management Team 38
Jun 05, 2017: Nexstim Members of the Board Committees 39
Jun 02, 2017: Nexstim Agrees on Extension of Tekes R&D Loan Repayments 40
Apr 24, 2017: Nexstim Appoints Hanna Kotola as VP of Legal Affairs 41
Mar 28, 2017: Nexstim: The decisions of the Board of Directors 42
Mar 09, 2017: Changes in Nexstim Management Team 43
Apr 21, 2016: Nexstim announces the change of CEO 44
Apr 01, 2016: Nexstim Appoints John Liedtky as VP of Commercialisation, General Manager US and announces the retirement of John Hardin 45
Product News 46
Jan 31, 2017: Neurosurgeons from Germany and USA report on their clinical experience of using Nexstim NBS system 46
Oct 05, 2016: Nexstim Key Technology Patent Granted in EU 47
Other Significant Developments 48
Oct 16, 2017: Nexstim is negotiating an assembly and distribution arrangement in China and a financing arrangement for the financing of its bring-to-market strategy in Europe and the US 48
May 08, 2017: Nexstim Terminates Market Making Agreement with Pareto Securities in Nasdaq First North Sweden 49
Apr 24, 2017: Aarhus University Hospital in Denmark Purchases NBS System from Nexstim 50
Mar 08, 2017: Nexstim announces signing of an Independent Selling Representative Agreement in the U.S. with Surgical Solutions 51
Jan 11, 2017: Nexstim announces signing of an Independent Selling Representative Agreements in U.S. 52
Dec 22, 2016: Nexstim pre-close business update 53
Appendix 54
Methodology 54
About GlobalData 54
Contact Us 54
Disclaimer 54

List of Tables
Nexstim Plc, Medical Equipment, Key Facts, 2015 2
Nexstim Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Nexstim Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Nexstim Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Nexstim Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Nexstim Plc, Deals By Market, 2011 to YTD 2017 9
Nexstim Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Nexstim Secures Additional US$2.8 Million In Venture Financing Round 11
Nexstim Enters into Licensing Agreement with Chinese Partner 13
Nexstim Enters into Co-Operation Agreement with Walton Centre 14
Nexstim to Raise USD2 Million in Private Placement of Shares 15
Nexstim to Raise USD5.5 Million in Private Placement of Shares 16
Nexstim to Raise USD2.2 Million in Private Placement of Shares 18
Nexstim Raises USD5.8 Million in Private Placement of Shares 20
Nexstim Raises USD19 Million in IPO 21
Nexstim to Raise USD5.5 Million in Private Placement of Convertible Bond 22
Nexstim Plc, Key Competitors 24
Nexstim Plc, Key Employees 25
Nexstim Plc, Subsidiaries 26

★海外企業調査レポート[Nexstim Plc (NXTMH)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ramsay Health Care Limited:企業の戦略・SWOT・財務分析
    Ramsay Health Care Limited - Strategy, SWOT and Corporate Finance Report Summary Ramsay Health Care Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Senzime AB (SEZI)-医療機器分野:企業M&A・提携分析
    Summary Senzime AB (Senzime) is a medical device company that develops patient-oriented monitoring systems. The company's product include TetraGraph monitor, CliniSenz analyzer, and Onzurf probe. Its TetraGraph monitor stimulates, measures, analyzes and displays muscle function in surgical patients …
  • Cantabio Pharmaceuticals Inc (CTBO):企業の財務・戦略的SWOT分析
    Summary Cantabio Pharmaceuticals Inc (Cantabio Pharmaceuticals) is a biotechnology company that concentrates on the commercializing of novel therapies for Parkinson’s disease, Alzheimer’s disease and neurodegenerative diseases. The company provide pipeline product candidates such as CB101 and CB102, …
  • Panhandle Oil and Gas Inc. (PHX)-石油・ガス分野:企業M&A・提携分析
    Summary Panhandle Oil and Gas Inc. (Panhandle) is an upstream oil and gas company that carries out exploration, development, production and sale of oil and natural gas. It is involved in the acquisition, management and development of non-operated oil and natural gas properties, including wells locat …
  • Casino Guichard-Perrachon SA:企業のM&A・事業提携・投資動向
    Casino Guichard-Perrachon SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Casino Guichard-Perrachon SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Metalico Inc:企業の戦略的SWOT分析
    Metalico Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Sodexo S.A.:戦略・SWOT・企業財務分析
    Sodexo S.A. - Strategy, SWOT and Corporate Finance Report Summary Sodexo S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • SR One Ltd-製薬・医療分野:企業M&A・提携分析
    Summary SR One Ltd (SR One), a subsidiary of GlaxoSmithKline Plc is a venture capital firm that offers investment services for seed, start up, early and mid venture; and emerging growth companies. The firm invests globally in emerging life science companies that are pursuing innovative science which …
  • Polarcus Ltd (PLCS):石油・ガス:M&Aディール及び事業提携情報
    Summary Polarcus Ltd (Polarcus) is a marine geophysical company that provides towed streamer data acquisition and imaging services. The company provides marine acquisition services such as vessel specifications, increasing efficiency, managing emissions to air, managing emissions to sea, polar code …
  • China Energy Conservation and Environmental Protection Group-エネルギー分野:企業M&A・提携分析
    Summary China Energy Conservation and Environmental Protection Group (CECEP) is a clean technology company that offers energy conservation, emission reduction and environment protection services. The company provides clean energy, energy saving, environmental protection, integrated services and reso …
  • Regen BioPharma Inc (RGBP):企業の財務・戦略的SWOT分析
    Summary Regen BioPharma Inc (Regen BioPharma), a subsidiary of Bio-Matrix Scientific Group Inc, is an immunology and immunotherapy space provider. The company concentrates on the development of immunotherapies and cancer stem cell therapies. Its product pipeline includes HemaXellerate, dCellVax, Dif …
  • Alphabet Inc:戦略・SWOT・企業財務分析
    Alphabet Inc - Strategy, SWOT and Corporate Finance Report Summary Alphabet Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Dis-Chem Pharmacies Limited (DCP):企業の財務・戦略的SWOT分析
    Dis-Chem Pharmacies Limited (DCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • International Flavors & Fragrances Inc.:戦略・SWOT・企業財務分析
    International Flavors & Fragrances Inc. - Strategy, SWOT and Corporate Finance Report Summary International Flavors & Fragrances Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • The Manufacturers Life Insurance Co:電力:M&Aディール及び事業提携情報
    Summary The Manufacturers Life Insurance Company (Manufacturers Life Insurance) is a financial service provider, based in Canada. The company provides financial protection, and wealth management products and services, and also asset management services to institutional customers. It offers individua …
  • Kkr Financial Holdings Llc
    Kkr Financial Holdings Llc - Strategy, SWOT and Corporate Finance Report Summary Kkr Financial Holdings Llc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Evonik Industries AG (EVK):製薬・医療:M&Aディール及び事業提携情報
    Summary Evonik Industries AG (Evonik), a subsidiary of RAG-Stiftung, is a specialty chemicals company. Its product portfolio includes surfactants, polymers, resins, additives and others. The company’s products find application in various markets, including adhesives and sealants, automotive, agricul …
  • Yokohama City University-製薬・医療分野:企業M&A・提携分析
    Summary Yokohama City University (YCU) is an educational university that provides various undergraduate and graduate courses. The institute offers graduate program in various courses such as international management, nanobioscience, medical life science and medicine. It conducts research that contri …
  • Lund University:製薬・医療:M&Aディール及び事業提携情報
    Summary Lund University (LNU) is an educational service provider that offers master and bachelor programmes. It offers education and research in the areas of engineering, economics and management, science, law, social sciences, medicine, humanities, theology, fine art, music and others. The universi …
  • International Business Machines Corporation:企業の戦略・SWOT・財務情報
    International Business Machines Corporation - Strategy, SWOT and Corporate Finance Report Summary International Business Machines Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆